Targeting XIST induced apoptosis of human osteosarcoma cells by activation of NF-kB/PUMA signal

References

• Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: osteosarcoma and related tumors. Cancer Genet Cytogenet. 2003;145:1–30.
   Google Scholar
• Meyers PA, Schwartz CL, Krailo M, et al. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol. 2005;23:2004–2011.
   Google Scholar
• Janeway KA, Grier HE. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol. 2010;11:670–678.
   Google Scholar
• Khanna C, Fan TM, Gorlick R, et al. Toward a drug development path that targets metastatic progression in osteosarcoma. Clin Cancer Res. 2014;20:4200–4209.
   Google Scholar
• Taniue K, Kurimoto A, Sugimasa H, et al. Long noncoding RNA UPAT promotes colon tumorigenesis by inhibiting degradation of UHRF1. Proc Natl Acad Sci USA. 2016;113:1273–1278.
   Google Scholar
• Gibb EA, Brown CJ, Lam WL. The functional role of long non-coding RNA in human carcinomas. Mol Cancer. 2011;10:38–46.
   Google Scholar
• Wang KC, Yang YW, Liu B, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472:120–124.
   Google Scholar
• Pintacuda G, Young AN, Cerase A. Function by structure: spotlights on xist long non-coding RNA. Front Mol Biosci. 2017;4:90–98.
   Google Scholar
• Zhuang LK, Yang YT, Ma X, et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203.
   Google Scholar
• Chang S, Chen B, Wang X, et al. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression. BMC Cancer. 2017;17:248–256.
   Google Scholar
• Mo Y, Lu Y, Wang P, et al. Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma. Tumour Biol. 2017;39:1010428317690999.
   Google Scholar
• Yang C, Wu K, Wang S, et al. Long non-coding RNA XIST promotes osteosarcomaprogression by targeting YAP via miR-195-5p. J Cell Biochem. 2018;119:5646–5656.
   Google Scholar
• Lv GY, Miao J, Zhang XL. Long noncoding RNA XIST promotes osteosarcomaprogression by targeting ras-related protein RAP2B via miR-320b. Oncol Res. 2018;26:837–846.
   Google Scholar
• Zhang R, Xia T. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis. Int J Oncol. 2017;51(5):1460–1470.
   Google Scholar
• Fatima R, Akhade VS, Pal D, et al. Long noncoding RNAs in development and cancer: potentialbiomarkers and therapeutic targets. Mol Cell Ther. 2015;3:5–13.
   Google Scholar
• Hayden MS, Ghosh S. NF-KB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 2012;26:203–234.
   Google Scholar
• Villunger A, Michalak EM, Coultas L, et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science. 2003;302:1036–1038.
   Google Scholar
• Han J, Flemington C, Houghton AB, et al. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA. 2001;98:11318–11323.
   Google Scholar
• Wang P, Qiu W, Dudgeon C, et al. PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell Death Differ. 2009;16:1192–1202.
   Google Scholar
• Thirukkumaran C, Shi ZQ, Thirukkumaran P, et al. PUMA and NF-kB are cell signaling predictors of reovirus oncolysis of breast cancer. PLoS One. 2017;12:e0168233.
   Google Scholar
• Hu G, Gong A-Y, Wang Y, et al. LincRNA-Cox2 promotes late inflammatory gene transcription in macrophages through modulating SWI/SNF-mediated chromatin remodeling. J Immunol. 2016;196:2799–2808.
   Google Scholar
• Wu H, Liu J, Li W, et al. LncRNA-HOTAIR promotes TNF-a production in cardiomyocytes of LPS-induced sepsis mice by activating NF-kB pathway. Biochem Biophys Res Commun. 2016;471:240–246.
   Google Scholar
• Li Z, Chao T-C, Chang K-Y, et al. The long noncoding RNA THRIL regulates TNFa expression through its interaction with hnRNPL. Proc Natl Acad Sci USA. 2014;111:1002–1007.
   Google Scholar
• Zhou Q, Huang XR, Yu J, et al. Long noncoding RNA Arid2-IR is a novel therapeutic target for renal inflammation. Mol Ther. 2015;23:1034–1043.
   Google Scholar
• Karin M, Lin A. NF-kappaB at the crossroads of life and death. Nat Immunol. 2012;3:221–227.
   Google Scholar
• Thapa RJ, Basagoudanavar SH, Nogusa S, et al. NF-kB protects cells from gamma interferon-induced RIP1-dependent necroptosis. Mol Cell Biol. 2011;31:2934–2946.
   Google Scholar
• Li X, Cao Y, Gong X, et al. Long noncoding RNAs in head and neck cancer. Oncotarget. 2017;8:10726–10740.
   Google Scholar
• Gutschner T, Diederichs S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012;9:703–719.
   Google Scholar
• Crea F, Watahiki A, Quagliata L, et al. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget. 2014;5:764–774.
   Google Scholar
• Hu B, Shi G, Li Q, et al. Long noncoding RNA XIST participates in bladder cancer by downregulating p53 via binding to TET1. J Cell Biochem. 2018;4:267–274.
   Google Scholar
• Cheng Q, Xu X, Jiang H, et al. Knockdown of long non-coding RNA XIST suppresses nasopharyngeal carcinoma progression by activating miR-491-5p. J Cell Biochem. 2018;119:3936–3944.
   Google Scholar
• Fang J, Sun CC, Gong C. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression. Biochem Biophys Res Commun. 2016;478:811–817.
   Google Scholar
• Sun K, Jia Z, Duan R, et al. Long non-coding RNA XIST regulates miR-106b-5p/P21 axis to suppress tumor progression in renal cell carcinoma. Biochem Biophys Res Commun. 2019;510(3):416–420.
   Google Scholar
• Du Y, Weng XD, Wang L, et al. LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression. Oncotarget. 2017;8:94358–94370.
   Google Scholar
• Xiao D, Cui X, Wang X. Long noncoding RNA XIST increases the aggressiveness of laryngeal squamous cell carcinoma by regulating miR-124-3p/EZH2. Exp Cell Res. 2019;14:30225–30233.
   Google Scholar
• Li C, Wan L, Liu Z, et al. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer. Cancer Lett. 2018;418:185–195.
   Google Scholar
• Sun J, Knickelbein K, He K, et al. Aurora kinase inhibition induces PUMA via NF-κB to kill colon cancer cells. Mol Cancer Ther. 2014;13:1298–1308.
   Google Scholar
• Ma M, Pei Y, Wang X, et al. LncRNA XIST mediates bovine mammary epithelial cell inflammatory response via NF-κB/NLRP3 inflammasome pathway. Cell Prolif. 2019;52:e12525.
   Google Scholar
• Zhao Y, Li S, Xia N, et al. Effects of XIST/miR-137 axis on neuropathic pain by targeting TNFAIP1 in a rat model. J Cell Physiol. 2018;233:4307–4316.
   Google Scholar